Therapeutic Potential against Alzheimer's Disease: In‐vitro 487.80 μg/mL of benzene extract showed significant (p < 0.05) inhibitory activity against both AChE and BuChE, with the percentage of inhibition 54.18 ± 5.65% (IC50 = 434.61 ± 26.53 μg/mL) and 78.43 ± 0% (IC50) = 163.01 ± 85.35 μg/mL). The gene discussed is ACHE; the disease is early-onset autosomal dominant Alzheimer disease.